Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANTAKE: Metformin Continuation for Peri-operative Glycemic Control in Type 2 Diabetes
NCT02571608Phase 4Withdrawn
- Sponsor
- McMaster University
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by McMaster University. Primary endpoint: Recruitment rate at 1 year. Planned start Jan 2022; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02571608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571608.